BRAF and thyroid cancer: Additionally, our focus on the BRAF V600E mutation, limited exploration of other prevalent molecular factors in thyroid cancer, and the observed discrepancies regarding HT and thyroid cancer risk highlight the need for more extensive molecular and mechanism research in this field.